Early fault detection and real-time condition monitoring systems have become quite significant for today's modern industrial systems. In a high volume of manufacturing facilities, fleets of equipment are expected to operate uninterrupted for days or weeks. Any unplanned interruptions to equipment uptime could jeopardize manufacturers' cycle time, capacity, and, most significantly, credibility for their customers. With the help of smart manufacturing technologies, companies have started to develop and integrate fault detection and classification systems where end-to-end constant monitoring of equipment is facilitated, and smart algorithms are adapted for the early generation of fault alarms and classification. This paper proposes a generic real-time fault diagnosis and condition monitoring system utilizing edge artificial intelligence (edge AI) and a data distributor open source middleware platform called FIWARE. The implemented system architecture is flexible and includes interfaces that can be easily expanded for various devices. This work demonstrates it for condition monitoring of autonomous transfer vehicle (ATV) equipment targeting a smart factory use case. The system is verified in a designated industrial model environment in a lab with a single ATV operation. The anomaly conditions of the ATV are diagnosed by a deep learning-based fault diagnosis method performed in the Edge AI unit, and the results are transferred to the data storage via a data pipeline setup. The proposed system's Edge AI solution for the ATV use case provides significant real-time performance. The network bandwidth requirement and total elapsed data transfer time have been reduced by 43 and 37 times, respectively. The proposed system successfully enables real-time monitoring of ATV fault conditions and expands to a fleet of equipment in a real manufacturing facility.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105012 | PMC |
http://dx.doi.org/10.3390/s22093208 | DOI Listing |
Clin Trials
January 2025
Department of Biostatistics, University of Washington, Seattle, WA, USA.
Background: N-of-1 trials compare two or more treatment options for a single participant. These trials have been used to study options for chronic conditions such as arthritis and attention deficit hyperactivity disorder. In addition, they have been suggested as a means to study interventions in rare populations that may not be tractable to include in standard clinical trials, such as treatment options for HIV-positive patients in need of organ transplant.
View Article and Find Full Text PDFDiabetes Obes Metab
January 2025
Department of Medicine, Division of Endocrinology, Diabetes Research Center, Columbia University Irving Medical Center, New York, New York, USA.
Objective: Post-prandial glucose response (PPGR) is a risk factor for cardiovascular disease. Meal carbohydrate content is an important predictor of PPGR, but dietary interventions to mitigate PPGR are not always successful. A personalized approach, considering behaviour and habitual pattern of glucose excursions assessed by continuous glucose monitor (CGM), may be more effective.
View Article and Find Full Text PDFFront Plant Sci
December 2024
College of Water Resources Science and Engineering, Taiyuan University of Technology, Taiyuan, China.
Introduction: Accurate diagnosis of the water status of fruit trees is a prerequisite for precise irrigation. Measurement of leaf turgor pressure provides a means to explore the water utilization mechanisms of fruit trees and their responses to water stress. However, there are few studies on the use of daily minimum leaf turgor pressure (Ppmax) to indicate water information in apple tree.
View Article and Find Full Text PDFCureus
December 2024
Department of Hematology, Japanese Red Cross Medical Center, Tokyo, JPN.
Elranatamab is an effective drug for triple-class-exposed relapsed/refractory multiple myeloma (TCE-RRMM). In the pivotal study, only grade 1 or 2 immune effector cell-associated neurotoxicity syndrome (ICANS) were reported, and the risk factors for immune effector cell-associated neurotoxicity syndrome have not yet been clearly elucidated. This case report documents the first case of grade 4 ICANS in a patient treated with elranatamab, presenting alongside grade 1 cytokine release syndrome (CRS).
View Article and Find Full Text PDFFront Cell Infect Microbiol
January 2025
Department of Food Biotechnology and Microbiology, Institute of Food Science Research (CIAL), CSIC-UAM, Madrid, Spain.
Background: SARS-CoV-2 and COVID-19 are still active in the population. Some patients remained PCR-positive for more than 4 weeks, called "persistently PCR-positive". Recent evidence suggests a link between the gut microbiota and susceptibility to COVID-19, although no studies have explored persistent PCR conditions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!